Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-446
Closed -$27K 1981
2018
Q2
$27K Buy
446
+81
+22% +$4.97K ﹤0.01% 1630
2018
Q1
$20K Hold
365
﹤0.01% 1965
2017
Q4
$20K Buy
365
+166
+83% +$7.96K ﹤0.01% 1965
2017
Q3
$8K Buy
199
+25
+14% +$1.06K ﹤0.01% 2257
2017
Q2
$6K Hold
174
﹤0.01% 2264
2017
Q1
$6K Hold
174
﹤0.01% 2264
2016
Q4
$6K Sell
174
-11
-6% -$361 ﹤0.01% 2217
2016
Q3
$5K Buy
185
+18
+11% +$518 ﹤0.01% 2284
2016
Q2
$4K Hold
167
﹤0.01% 2303
2016
Q1
$4K Sell
167
-248
-60% -$6.07K ﹤0.01% 2294
2015
Q4
$10K Hold
415
﹤0.01% 2079
2015
Q3
$12K Hold
415
﹤0.01% 2068
2015
Q2
$15K Sell
415
-59
-12% -$2.13K ﹤0.01% 1997
2015
Q1
$15K Buy
474
+47
+11% +$1.57K ﹤0.01% 2032
2014
Q4
$14K Buy
+427
New +$15K ﹤0.01% 2141

Other funds holding KLXI

Glenmede Trust's KLXI Position: Q3 2018 in Review

Glenmede Trust sold out of KLX Inc. (KLXI) in Q3 2018, closing a stake of 446 shares — an estimated $27K sold.

Glenmede Trust first reported a position in KLXI in Q4 2014 and held it in 15 quarters. The position peaked at $27K in Q2 2018. 214 funds tracked by Wall St. Rank hold KLXI as of Q3 2018.

  • Glenmede Trust reported no remaining KLX Inc. position as of Q3 2018 after selling out during the quarter.
  • Glenmede Trust sold 446 KLX Inc. shares in Q3 2018, an estimated $27K.
  • Glenmede Trust first reported a position in KLX Inc. in Q4 2014 and held it in 15 quarters.
  • Glenmede Trust's KLX Inc. position peaked at $27K in Q2 2018.
  • 214 funds tracked by Wall St. Rank held KLX Inc. as of Q3 2018.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.